Journal
EXPERT REVIEW OF ANTICANCER THERAPY
Volume 8, Issue 3, Pages 393-402Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1586/14737140.8.3.393
Keywords
chemotherapy; radiation therapy; salivary gland tumors; surgery; targeted therapy
Categories
Ask authors/readers for more resources
Salivary gland carcinomas are rare cancers, comprising 1-5% of head and neck cancers. They represent a morphologically and clinically diverse group of tumors. The most commonly histopathologic types are mucoepidermoid cancer, adenoid cystic cancer and adenocarcinomas. Malignant salivary gland tumors generally present as painless, slow-growing tumors that are indistinguishable from benign tumors. Surgery is the principal treatment and is curative in early stage. Radiation therapy should be considered in most patients after surgical resection. Chemotherapy is reserved for palliative treatment of metastatic disease but results are disappointing. Recent studies have investigated the role of targeted therapies in a palliative setting. Multicentre cooperative group clinical trials are required to assess novel therapies to maximize patient resources in this uncommon tumor.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available